Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022 Overview



This report studies the Animal Stem Cell Therapy market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Animal Stem Cell Therapy market by product and Application/end industries.

Publisher: QYResearch
Published Date: 2018/6/5



Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease.

In the last several years, global market of Animal Stem Cell Therapy developed rapidly, with an average growth rate of 23.85%. In 2016, global revenue of Animal Stem Cell Therapy is nearly 10.7 M USD.

The classification of Animal Stem Cell Therapy includes dogs, horses and others, and the proportion of dogs in 2016 is about 51%, and the proportion is in increasing trend from 2012 to 2016.

Animal Stem Cell Therapy is widely used in veterinary hospitals and research organizations. The most proportion of Animal Stem Cell Therapy is used in veterinary hospitals, and the revenue in 2016 is 8.09 M USD.

North America is the largest consumption region of Animal Stem Cell Therapy, with a consumption market share nearly 55% in 2016. Japan is the second largest supplier of Animal Stem Cell Therapy, enjoying production market share nearly 21% in 2016.

Market competition is intense. VETSTEM BIOPHARMA, MediVet Biologic, J-ARM, Celavet, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. 


This article was first released by QYResearch, if reproduced, please indicate the source.
Marketing: sales@qyresearch.com
Media Contact: press@qyresearch.com

评论

热门博文